文献速递中药与中成药合理使用中医内科

去氢吴茱萸碱的药代动力学、药理特性与毒性风险综述

The pharmacokinetics profiles, pharmacological properties, and toxicological risks of dehydroevodiamine: A review.
PubMed 文献 · Front Pharmacol · 2022-11-18

去氢吴茱萸碱(DHE)是中药吴茱萸中的喹唑啉生物碱,本综述首次系统总结其药代动力学、药理特性与毒性风险。DHE口服吸收较好,在大鼠血浆中呈多峰现象,具中枢、心血管、消化系统等多方面药理活性及抗炎作用,但存在致心律失常和影响胆汁酸稳态的毒性风险,需进一步严谨研究。

要点

  • DHE口服吸收较好,大鼠血浆浓度曲线呈多峰,可能与分布再吸收和肠肝循环有关。
  • DHE具中枢、心血管、消化系统药理活性及抗炎作用,有望成为多种疾病的潜在药物。
  • 毒性研究提示DHE有致心律失常作用并可影响胆汁酸稳态,但未致肝毒性。

核心结论

  • DHE具有较好的口服吸收和广泛药理活性,但存在致心律失常及影响胆汁酸稳态的毒性风险,需进一步严谨研究阐明其药代、药理机制和毒性。

研究设计与样本

  • 本文为综述,首次系统总结DHE的药代动力学、药理特性和毒性风险研究。
  • 药代动力学研究基于大鼠血浆平均浓度曲线评估DHE口服吸收。

主要发现

  • 药代研究显示DHE在大鼠血浆平均浓度曲线中口服吸收效果较好,胃肠道吸收高。
  • DHE在大鼠血浆中可能出现多个血药浓度峰值,分布再吸收和肠肝循环可能是其原因。
  • DHE在中枢神经系统、心血管系统和消化系统具有广泛药理特性。
  • DHE通过下调促炎细胞因子和炎症介质发挥抗炎作用。
  • 毒性研究提示DHE有致心律失常作用并可损害胆汁酸稳态,但不引起肝毒性。

临床怎么用

  • DHE有望作为治疗阿尔茨海默病、慢性应激、遗忘症、慢性萎缩性胃炎、胃溃疡和类风湿关节炎的潜在药物候选。
  • 临床应用需关注DHE的致心律失常风险及对胆汁酸稳态的影响。

局限性

  • 需进一步严谨且设计良好的研究来阐明DHE的药代动力学、药理效应、潜在生物学机制和毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dehydroevodiamine (DHE) is a quinazoline alkaloid isolated from Evodiae Fructus (EF, Wuzhuyu in Chinese, Rutaceae family), a well-known traditional Chinese medicine (TCM) which is clinically applied to treat headache, abdominal pain, menstrual pain, abdominal distension, vomiting, acid regurgitation, etc. Modern research demonstrates that DHE is one of the main components of EF. In recent years, DHE has received extensive attention due to its various pharmacological activities. This review is the first to comprehensively summarize the current studies on pharmacokinetics profiles, pharmacological properties, and toxicological risks of DHE in diverse diseases. Pharmacokinetic studies have shown that DHE has a relatively good oral absorption effect in the mean concentration curves in rat plasma and high absorption in the gastrointestinal tract. In addition, distribution re-absorption and enterohepatic circulation may lead to multiple blood concentration peaks of DHE in rat plasma. DHE possesses a wide spectrum of pharmacological properties in the central nervous system, cardiovascular system, and digestive system. Moreover, DHE has anti-inflammatory effects via downregulating pro-inflammatory cytokines and inflammatory mediators. Given the favorable pharmacological activity, DHE is expected to be a potential drug candidate for the treatment of Alzheimer's disease, chronic stress, amnesia, chronic atrophic gastritis, gastric ulcers, and rheumatoid arthritis. In addition, toxicity studies have suggested that DHE has proarrhythmic effects and can impair bile acid homeostasis without causing hepatotoxicity. However, further rigorous and well-designed studies are needed to elucidate the pharmacokinetics, pharmacological effects, potential biological mechanisms, and toxicity of DHE.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Fu S, Liao L, Yang Y, et al. The pharmacokinetics profiles, pharmacological properties, and toxicological risks of dehydroevodiamine: A review. Front Pharmacol. 2022. PMID: 36467053. doi:10.3389/fphar.2022.1040154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。